Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 17;21(8):2806.
doi: 10.3390/ijms21082806.

Macrophage Phenotype and Fibrosis in Diabetic Nephropathy

Affiliations
Review

Macrophage Phenotype and Fibrosis in Diabetic Nephropathy

Priscila Calle et al. Int J Mol Sci. .

Abstract

Diabetic nephropathy (DN) is the leading cause of end-stage renal disease globally. The primary initiating mechanism in DN is hyperglycemia-induced vascular dysfunction, but its progression is due to different pathological mechanisms, including oxidative stress, inflammatory cells infiltration, inflammation and fibrosis. Macrophages (Mφ) accumulation in kidneys correlates strongly with serum creatinine, interstitial myofibroblast accumulation and interstitial fibrosis scores. However, whether or not Mφ polarization is involved in the progression of DN has not been adequately defined. The prevalence of the different phenotypes during the course of DN, the existence of hybrid phenotypes and the plasticity of these cells depending of the environment have led to inconclusive results. In the same sense the role of the different macrophage phenotype in fibrosis associated or not to DN warrants additional investigation into Mφ polarization and its role in fibrosis. Due to the association between fibrosis and the progressive decline of renal function in DN, and the role of the different phenotypes of Mφ in fibrosis, in this review we examine the role of macrophage phenotype control in DN and highlight the potential factors contributing to phenotype change and injury or repair in DN.

Keywords: diabetic nephropathy; fibrosis; macrophages.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Macrophages in diabetic nephropathy. High glucose levels, tubular-reabsorbed protein, advanced glycation end products (AGEs), angiotensin-II (AT-II) and proinflammatory cytokines induce the production of MCP-1 by kidney tubular cells and podocytes. As a consequence, kidney monocyte recruitment is provoked. In the tissue, monocytes are converted in macrophages that acquire the M1, M2 or mixed phenotype depending on the inflammatory milieu and the molecules released by these different macrophage populations. M1 provokes injury and M2 are proresolution and regenerative macrophages that could induce fibrosis, while mixed macrophages could acquire different roles depending on the milieu. Macrophage image by Mikael Häggström, used with permission.

References

    1. Collins A.J., Foley R.N., Chavers B., Gilbertson D., Herzog C., Johansen K., Kasiske B., Kutner N., Liu J., St. Peter W., et al. United States renal data system 2011 annual data report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am. J. Kidney Dis. 2012;59:e1–e420. - PubMed
    1. Nguyen D., Ping F., Mu W., Hill P., Atkins R.C., Chadban S.J. Macrophage accumulation in human progressive diabetic nephropathy. Nephrology. 2006;11:226–231. doi: 10.1111/j.1440-1797.2006.00576.x. - DOI - PubMed
    1. Klessens C.Q.F., Zandbergen M., Wolterbeek R., Bruijn J.A., Rabelink T.J., Bajema I.M., IJpelaar D.H.T. Macrophages in diabetic nephropathy in patients with type 2 diabetes. Nephrol. Dial. Transplant. 2017;32:1322–1329. doi: 10.1093/ndt/gfw260. - DOI - PubMed
    1. Furuta T., Saito T., Ootaka T., Soma J., Obara K., Abe K., Yoshinaga K. The role of macrophages in diabetic glomerulosclerosis. Am. J. Kidney Dis. 1993;21:480–485. doi: 10.1016/S0272-6386(12)80393-3. - DOI - PubMed
    1. Hirata K., Shikata K., Matsuda M., Akiyama K., Sugimoto H., Kushiro M., Makino H. Increased expression of selectins in kidneys of patients with diabetic nephropathy. Diabetologia. 1998;41:185–192. doi: 10.1007/s001250050888. - DOI - PubMed